A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes

Introduction

(2016)   DIABETES CARE

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM –2016 EXECUTIVE SUMMARY

(2016) Alan J. Garber et al.   Endocrine Practice

Initiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix Regimens

(2016) Michelle Downie et al.   Diabetes Therapy

Initiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix Regimens

(2016) Michelle Downie et al.   Diabetes Therapy

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)

(2015) J. Vora et al.   DIABETES OBESITY & METABOLISM

Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial

(2015) Sang-Man Jin et al.   Journal of Diabetes

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes

(2015) Ted Wu et al.   Diabetes Therapy

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes

(2015) Ted Wu et al.   Diabetes Therapy

Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial

(2014) F. J. Tinahones et al.   DIABETES OBESITY & METABOLISM

A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus - a systematic review and meta-analysis

(2014) P. Rys et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Intensifying Insulin Therapy: What Options Are Available to Patients with Type 2 Diabetes?

(2013) Luigi F. Meneghini   AMERICAN JOURNAL OF MEDICINE

Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes

(2013) Rehan Qayyum et al.   ANNALS OF INTERNAL MEDICINE

Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial

(2013) Helena W Rodbard et al.   Lancet Diabetes & Endocrinology

A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study

(2012) K. Bowering et al.   DIABETIC MEDICINE

Stepwise intensification of insulin therapy in Type 2 diabetes management-exploring the concept of the basal-plus approach in clinical practice

(2012) D. R. Owens   DIABETIC MEDICINE

Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being

(2012) Meryl Brod et al.   QUALITY OF LIFE RESEARCH

An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study

(2011) Philip Home et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

(2009) Krzysztof Strojek et al.   CURRENT MEDICAL RESEARCH AND OPINION

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE